Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-05-002865
Filing Date
2005-03-21
Accepted
2005-03-21 06:10:16
Documents
7
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 KING PHARMACEUTICALS, INC. g93180e10vk.htm 10-K 2321711
2 EX-21.1 LIST OF SUBSIDIARIES g93180exv21w1.txt EX-21.1 1110
3 EX-23.1 CONSENT OF PRICEWATERHOUSCOOPERS LLP g93180exv23w1.txt EX-23.1 894
4 EX-31.1 SECTION 302 CERTIFICATION OF THE CEO g93180exv31w1.txt EX-31.1 4317
5 EX-31.2 SECTION 302 CERTIFICATION OF THE CFO g93180exv31w2.txt EX-31.2 4240
6 EX-32.1 SECTION 906 CERTIFICATION OF THE CEO g93180exv32w1.txt EX-32.1 1196
7 EX-32.2 SECTION 906 CERTIFICATION OF THE CFO g93180exv32w2.txt EX-32.2 1103
  Complete submission text file 0000950144-05-002865.txt   2336955
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

EIN.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15875 | Film No.: 05693021
SIC: 2834 Pharmaceutical Preparations